Search
for
Sort by
Research 30 of 1000+
- Changing incidence trends of cutaneous B-cell lymphoma
- Advanced Breast Cancer in Young Women
- The evolution of primary multimodality treatment in resectable breast cancer
- Lung Cancer Chemoprevention with Retinol Palmitate: Preliminary data from a randomized trial on stage la non small-cell lung cancer
- Reporte de caso: Presentación clínica e importancia de coinfecciones durante pandemia por COVID-19 en pacientes con neoplasias malignas
- Regaining Control Over Cancer: A Health Communication Initiative Documenting Complementary and Alternative Medicine Use Among Cancer Patients and Survivors
- Sun-protection behaviors of melanoma survivors
- Inflammatory and non-melanocytic tumoral pathology of the nail
- Synthesis, Characterisation, andIn VitroAnticancer Activity of Curcumin Analogues Bearing Pyrazole/Pyrimidine Ring Targeting EGFR Tyrosine Kinase
- Removing all obstacles: A critical role for p53 in promoting tissue renewal
- 1450 THE TRUE BENEFIT OF PSA-SCREENING: MODELING THE IMPACT OF TRIAL SETTING AND PROTOCOL ON MORTALITY
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- High Response Rate to Bexxar in Advanced Stage Prior Treatment-Resistant Follicular Lymphoma
- Telogen Effluvium
- Topical liposome delivery of molecules to hair follicles in mice
- A MODERN VIEW OF THE POLYCYSTIC OVARIAN SYNDROME
- Diverse cellular players orchestrate regeneration after wounding
- Hair growth in vitro from histocultured skin
- Stem cell dynamics in the hair follicle niche
- Prevalence and Partern of Early Adverse Reactions in Cancer Patients Receiving Chemotherapy at Ocean Road Cancer Institute
- Anais do II Congresso Nacional Acadêmico de Dermatologia
- Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
- High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease
- Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study
- PD57-09 NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM SURGICAL RISK CALCULATOR POORLY PREDICTS COMPLICATIONS IN PATIENTS UNDERGOING RADICAL CYSTECTOMY WITH URINARY DIVERSION: THE CASE FOR A PROCEDURE-SPECIFIC RISK CALCULATOR
- Drug utilization pattern and adverse drug reactions of chemotherapy in pediatric patients at Muhimbili National Hospital, Tanzania
- Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment